Civic Intelligence

Eye Samaritans International

990EZ • Fiscal year 2018 • EIN 46-1046320

Jan 01, 2018 to Dec 31, 2018

Shreveport, LA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

57th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Liabilities / Revenue

56th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Net Margin

94th percentile

61%

Higher net margin than 94% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2018

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2018

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2018

Assets

$139,900

No earlier filing loaded for comparison.

Net Assets

-

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$167,375

No earlier filing loaded for comparison.

Expenses

$65,059

No earlier filing loaded for comparison.

Net Income

$102,316

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$150K$100K$50K$0Assets 2018: $139,900Liabilities 2018: $02018Assets 2019: $62,378Liabilities 2019: $0Net Assets 2019: $62,3782019Assets 2020: $88,856Liabilities 2020: $0Net Assets 2020: $88,8562020Assets 2021: $121,641Liabilities 2021: $2,207Net Assets 2021: $119,4342021Assets 2022: $103,294Net Assets 2022: $103,2942022Assets 2023: $68,920Net Assets 2023: $68,9202023Assets 2024: $55,672Liabilities 2024: $55,672Net Assets 2024: $55,6722024

Highlighted filing

2018

Assets$139,900
Liabilities$0
Net Assets-

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$300K$200K$100K$0-$100KRevenue 2018: $167,375Expenses 2018: $65,059Net Income 2018: $102,3162018Revenue 2019: $58,600Expenses 2019: $136,122Net Income 2019: -$77,5222019Revenue 2020: $284,237Expenses 2020: $257,759Net Income 2020: $26,4782020Revenue 2021: $142,101Expenses 2021: $111,523Net Income 2021: $30,5782021Revenue 2022: $50,752Expenses 2022: $66,892Net Income 2022: -$16,1402022Revenue 2023: $40,183Expenses 2023: $74,555Net Income 2023: -$34,3722023Revenue 2024: $95,740Expenses 2024: $108,988Net Income 2024: -$13,2482024

Highlighted filing

2018

Revenue$167,375
Expenses$65,059
Net Income$102,316
Filing Detail Status

This 2018 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2018 to Dec 31, 2018
Mission and Program Overview

Mission

To treat and prevent retinopathy of prematurity in eastern europe, black sea countries, and russian federation and where half their babies go blind from rop. To reduce blindness from retinopathy of prematurity(rop) in target countries.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings